German watchdog approves Novo`s acquisition of Cardior Pharmaceuticals
19 Apr 2024 //
REUTERS
Novo Nordisk strikes deal worth up to $1.1 bln to expand cardio business
26 Mar 2024 //
REUTERS
Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board
01 Dec 2022 //
BUSINESSWIRE
Cardior Announces CE Marking of CardiorHealth miR-132 PCR Kit
08 Sep 2022 //
BUSINESSWIRE
Cardior Begins Dosing in PII Study of Non-coding RNA-Based Candidate CDR132L
20 Jul 2022 //
BUSINESSWIRE
Cardior Appoints Dr. Russell Greig as Independent Chairman of the Board
06 Apr 2022 //
BUSINESSWIRE
Cardior Appoints Cardiac Disease and RNA Drug Development Experts
02 Mar 2022 //
BUSINESSWIRE
Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics
25 Aug 2021 //
BUSINESSWIRE
Cardior gets $75M to run midphase antisense heart failure trial
25 Aug 2021 //
FIERCEBIOTECH
Cardior Appoints Dr. Rahul Agrawal as Chief Medical Officer
01 Jul 2021 //
BUSINESSWIRE
Cardior ` Lead Compound Demonstrates Improvement of Heart
22 Oct 2020 //
GFIRSTWORLDPHARMA